NDCFind

Krystexxa 75987-0080

Generic: Pegloticase

Product NDC

75987-0080
Manufacturer
Horizon Therapeutics Usa, Inc.
Dosage Form
Injection, Solution
Route
Intravenous
Product Type
Human Prescription Drug
Marketing Start
September 14, 2010
Listing Expires
December 31, 2027
Application
BLA125293
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Krystexxa? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Pegloticase8 mg/mL

Drug Class

Uric Acid-specific Enzyme [EPC]Urate Oxidase [CS]Uric Acid-specific Enzyme [EPC]

Packaging Options(1)

1 VIAL in 1 CARTON (75987-080-10) / 1 mL in 1 VIAL